An article in the New Zealand Medical Journal (Feb 11, 2000;113(1103):24–26) raised concerns about the potential effects of high soy consumption on thyroid function, particularly in infants fed soy-based formulas.
Concerns for Infants
The author summarized the position of the New Zealand Ministry of Health at that time:
“The Ministry of Health has found that infants with a history of thyroid dysfunction should avoid soy formulas and soy milks. Additionally, there is potential for isoflavone exposure to cause chronic thyroid damage in all infants fed soy formulas.”
Isoflavones—naturally occurring compounds found in soy—can interfere with thyroid hormone production under certain conditions, particularly when iodine intake is inadequate. The article argued that because infants consuming soy formula may be exposed daily to relatively high amounts of isoflavones, caution is warranted.
The author recommended that manufacturers consider removing isoflavones from soy-based formulas and stated:
“In the interim, it is appropriate for medical practitioners to monitor the thyroid status of infants fed soy formulas.”
Areas of Controversy
Not all researchers agree with this position. Points of debate include:
-
Iodine fortification: Some experts believe that when soy formulas are adequately fortified with iodine, potential thyroid effects are reduced or eliminated.
-
Lack of demonstrated causation: As the article acknowledges, many researchers do not see a clear cause–effect relationship between soy consumption and thyroid dysfunction.
-
Variability in individual susceptibility: Genetics, iodine intake, and underlying thyroid status may all influence risk.
Overall, the discussion reflects ongoing scientific uncertainty about how isoflavones interact with thyroid physiology in infants, especially in populations with varying iodine intake. For a broader overview of thyroid symptoms, testing, and thyroid disorders, see Thyroid Health: Symptoms, Testing, and Common Thyroid Disorders.
Educational only — not medical advice.
